Combined Food and Drug Administration and Sponsor Oncologic Drugs Advisory Committee Briefing Document
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
December 27, 2024
January 3, 2025
acf14472-e5b8-47ba-a5bd-76d6bae8bd27
Related Documents
Drug Master Files Guidance for Industry
Guidance DocumentNovember 15, 2019Center for Drug Evaluation and Research
Tissue Agnostic Drug Development in Oncology: Draft Guidance for Industry
Guidance DocumentOctober 17, 2022Office of the Commissioner
Biomarker Qualification: Evidentiary Framework: Draft Guidance for Industry and FDA Staff
Guidance DocumentDecember 12, 2018Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.